Drug Shortage Report for MYLAN-LANSOPRAZOLE

Last updated on 2018-08-15 History
Report ID 14700
Drug Identification Number 02353830
Brand name MYLAN-LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 15MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-08-10
Actual start date 2018-08-07
Estimated end date 2018-08-30
Actual end date 2018-08-14
Shortage status Resolved
Updated date 2018-08-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2017-11-24 French Compare
v29 2017-11-24 English Compare
v28 2017-11-23 French Compare
v27 2017-11-23 English Compare
v26 2017-11-22 French Compare
v25 2017-11-22 English Compare
v24 2017-11-20 French Compare
v23 2017-11-20 English Compare
v22 2017-10-12 English Compare
v21 2017-10-11 French Compare
v20 2017-10-11 English Compare
v19 2017-10-06 English Compare
v18 2017-09-21 French Compare
v17 2017-09-21 English Compare
v16 2017-09-08 French Compare
v15 2017-09-08 English Compare
v14 2017-08-29 French Compare
v13 2017-08-29 English Compare
v12 2017-08-22 French Compare
v11 2017-08-22 English Compare

Showing 41 to 60 of 70